Agitation in Alzheimer Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-07-07
Clinical Trial Update: Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial update evaluating flexible dosing of brexpiprazole for agitation in Alzheimer's disease; study completed with results posted.